Somatic forward genetic screens have the power to interrogate thousands of genes in a single animal. Retroviral and transposon mutagenesis systems in mice have been designed and deployed in somatic tissues for surveying hematopoietic and solid tumor formation. In the context of cancer, the ability to visually mark mutant cells would present tremendous advantages for identifying tumor formation, monitoring tumor growth over time, and tracking tumor infiltrations and metastases into wild-type tissues. Furthermore, locating mutant clones is a prerequisite for screening and analyzing most other somatic phenotypes. For this purpose, we developed a system using the piggyBac (PB) transposon for somatic mutagenesis with an activated reporter and tr...
Genetically engineered mouse (GEM) models of cancer currently comprise the most accurate way to expe...
piggyBac-mediated long-term gene expression 2 Transposons are promising systems for somatic gene int...
A new method is developed for estimating rates of somatic mutation in vivo. The stop-enhanced green ...
Somatic forward genetic screens have the power to interrogate thousands of genes in a single animal....
Transposons are mobile DNA segments that can disrupt gene function by inserting in or near genes. He...
In the last decades, many important genes responsible for the genesis of various cancers have been d...
Transposon-mediated forward genetics screening in mice has emerged as a powerful tool for cancer gen...
B-cell lymphoma (BCL) is the most common hematologic malignancy. While sequencing studies gave insig...
Large-scale cancer genome projects will soon be able to sequence many cancer genomes to comprehensiv...
Somatic transposon mutagenesis in mice is an efficient strategy to investigate the genetic mechanism...
We describe a screen for cellular response to drugs that makes use of haploid embryonic stem cells. ...
<p>Potential oncogenic pathway to be interrogated with candidate oncogene X and effector Y in red (l...
The in vivo validation of cancer mutations and genes identified in cancer genomics is resource-inten...
We describe a screen for cellular response to drugs that makes use of haploid embryonic stem cells. ...
Transposons are an attractive system to use in genetic screens as they are molecularly tractable and...
Genetically engineered mouse (GEM) models of cancer currently comprise the most accurate way to expe...
piggyBac-mediated long-term gene expression 2 Transposons are promising systems for somatic gene int...
A new method is developed for estimating rates of somatic mutation in vivo. The stop-enhanced green ...
Somatic forward genetic screens have the power to interrogate thousands of genes in a single animal....
Transposons are mobile DNA segments that can disrupt gene function by inserting in or near genes. He...
In the last decades, many important genes responsible for the genesis of various cancers have been d...
Transposon-mediated forward genetics screening in mice has emerged as a powerful tool for cancer gen...
B-cell lymphoma (BCL) is the most common hematologic malignancy. While sequencing studies gave insig...
Large-scale cancer genome projects will soon be able to sequence many cancer genomes to comprehensiv...
Somatic transposon mutagenesis in mice is an efficient strategy to investigate the genetic mechanism...
We describe a screen for cellular response to drugs that makes use of haploid embryonic stem cells. ...
<p>Potential oncogenic pathway to be interrogated with candidate oncogene X and effector Y in red (l...
The in vivo validation of cancer mutations and genes identified in cancer genomics is resource-inten...
We describe a screen for cellular response to drugs that makes use of haploid embryonic stem cells. ...
Transposons are an attractive system to use in genetic screens as they are molecularly tractable and...
Genetically engineered mouse (GEM) models of cancer currently comprise the most accurate way to expe...
piggyBac-mediated long-term gene expression 2 Transposons are promising systems for somatic gene int...
A new method is developed for estimating rates of somatic mutation in vivo. The stop-enhanced green ...